PARIS and CAMBRIDGE, UK – January 11, 2021 – Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology therapeutics, have entered into an agreement under which Sanofi will acquire Kymab for an upfront
News
Wädenswil/Zurich, Switzerland and Saffron Walden, UK, 12th January 2021 / Domainex Ltd., a leading provider of integrated drug discovery services, is pleased to announce that it has invested in the WAVEdelta instrument from Creoptix AG. This instrument utilizes Grating-Coupled Interferometry (GCI) to measure target binding on sensor chips, generating binding affinity and on/off rate kinetics in a high throughput manner.
Tokyo, Japan and Cambridge, UK, 11 January 2021 – Sosei Group Corporation (“the Company”; TSE: 4565), today announced its Chief Financial Officer, Chris Cargill, will present at the 39th Annual J.P. Morgan Healthcare Conference, which will take place virtually, on Thursday, 14 January 2021.
A new way for Cambridge businesses and research institutions to connect to key sites and communities across Europe is now available thanks to Light Blue Fibre, bandwidth infrastructure provider euNetworks, and the UK Innovation Corridor’s most advanced data centre, Kao Data.
Light Blue Fibre, which was launched as a joint venture by University of Cambridge and Cambridgeshire County Council in 2019 is now being enabled by euNetworks, which specialises in data-centre-to-data-centre connectivity across the UK and Europe.
Cambridge, UK, 11 January 2021: Mogrify Limited (Mogrify®), a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, and the MRC Laboratory of Molecular Biology (LMB), a world-class research laboratory dedicated to understanding important biological processes at the molecular level, today announced an exploratory research collaboration.
With facilities already in Shanghai and Beijing, Biocair recently announced the opening of its new office in Guangzhou.
Strategically located close to Guangzhou Airport, the new office improves operational capacity, and employs a team of logistics experts with comprehensive knowledge of the local customer base, transport network and import / export regulations. Temperature-controlled vehicles will join Biocair China’s existing fleet to provide efficient, secure and compliant transportation for time and temperature-sensitive biological materials.
NORWICH, UK – 07 January 2021: Leaf Expression Systems (Leaf), a contract development and manufacturing organisation based in Norwich, UK, has announced today that it has produced three further products to support research into the Novel Coronavirus (SARS-CoV-2, 2019-nCoV) pandemic.
The products developed include:
AMSBIO has introduced a series of kit products based upon high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development.
These new kit products include SARS-CoV-2 inhibitor screening kits, antibody titer serologic assay kits, antigen detection kit and antigen pre-coated plates.
Cambridge 04 January 2021: Babraham Bioscience Technologies Ltd (BBT), the organisation which oversees the development and day-to-day management of the Babraham Research Campus is pleased to welcome three new members to its board.